Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

403
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
403
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A biomechanical-constrained temporal learning framework for lightweight skeleton-based exercise recognition.

Scientific reports·2026
Same author

AI-enhanced routing and slicing strategy for QoS-aware mobile ad hoc networks.

Scientific reports·2026
Same author

Trustworthy deep learning for malaria diagnosis using explainable artificial intelligence.

Scientific reports·2025
Same author

Responsible Detection and Mitigation of AI-Generated Text Using Hybrid Neural Networks and Feature Fusion: Toward Trustworthy Content Management in the Era of Large Language Models.

International journal of computational intelligence systems·2025
Same author

FISM: harnessing deep learning and reinforcement learning for precision detection of microaneurysms and retinal exudates for early diabetic retinopathy diagnosis.

BioData mining·2025
Same author

Machine Learning-Based Validation of LDHC and SLC35G2 Methylation as Epigenetic Biomarkers for Food Allergy.

Biomedicines·2025
Same journal

Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. <i>Diagnostics</i> 2026, <i>16</i>, 1224.

Diagnostics (Basel, Switzerland)·2026
Same journal

Association Between Systemic Inflammatory Response Biomarkers and Disease Activity in Systemic Lupus Erythematosus: A Multi-Center Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same journal

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same journal

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation.

Diagnostics (Basel, Switzerland)·2026
Same journal

Data-Efficient and Explainable Multimodal Survival Prediction in NSCLC Using Deep Image Embeddings, Clinical Variables, and Gradient-Boosted Trees.

Diagnostics (Basel, Switzerland)·2026
Same journal

Anomalous Left Coronary Artery from the Pulmonary Artery: Cinematic Volume Rendering Technique for Enhanced Anatomic Visualization.

Diagnostics (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jul 30, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

A Novel Hybrid Runge Kutta Optimizer with Support Vector Machine on Gene Expression Data for Cancer Classification.

Essam H Houssein1, Hager N Hassan1, Nagwan Abdel Samee2

  • 1Faculty of Computers and Information, Minia University, Minia 61519, Egypt.

Diagnostics (Basel, Switzerland)
|May 13, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a novel RUN-SVM approach for accurate cancer classification using gene expression data. The method effectively identifies significant genes, outperforming other algorithms in cancer detection.

Keywords:
Runge Kutta optimizercancer classificationfeature selectiongene expressionmicroarraysupport vector machines

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

815
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Related Experiment Videos

Last Updated: Jul 30, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

815
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Accurate cancer categorization from microarray data is essential for effective diagnosis and treatment.
  • Gene expression analysis is a key tool in cancer research, but high dimensionality poses challenges.
  • Identifying informative genes is critical for improving cancer classification accuracy.

Purpose of the Study:

  • To develop and evaluate a novel computational approach for selecting significant genes for cancer classification using microarray data.
  • To enhance the accuracy of cancer detection by effectively handling high-dimensional gene expression datasets.
  • To assess the performance of the proposed method against existing algorithms on various cancer datasets.

Main Methods:

  • A hybrid approach combining the Runge Kutta optimizer (RUN) for gene selection and Support Vector Machine (SVM) for classification.
  • Implementation of the ReliefF method for preprocessing high-dimensional microarray data to reduce noise and redundancy.
  • Testing the RUN-SVM approach on diverse binary-class (Breast2, Prostate) and multi-class (Brain Tumor1, Brain Tumor2, Breast3, Lung Cancer) cancer gene expression datasets.

Main Results:

  • The proposed RUN-SVM approach demonstrated superior performance in identifying significant genes for cancer classification.
  • Statistical analysis confirmed that RUN-SVM significantly outperformed competing algorithms across six different cancer gene expression datasets.
  • The method effectively addressed the challenge of high dimensionality inherent in microarray data.

Conclusions:

  • The novel RUN-SVM approach offers a robust and effective solution for gene selection in cancer classification.
  • This method provides a statistically significant improvement over existing algorithms for cancer detection using gene expression data.
  • The innovative search technique employed by RUN-SVM contributes to its enhanced performance in analyzing complex biological datasets.